178 related articles for article (PubMed ID: 36647653)
41. Prognostic value of miR-892a in gastric cancer and its regulatory effect on tumor progression.
Lv J; Zhang H; Gao Z; Zhang X; Huang X; Jia X
Cancer Biomark; 2020; 28(2):247-254. PubMed ID: 32390603
[TBL] [Abstract][Full Text] [Related]
42. CA19‑9 is a significant prognostic factor in stage III gastric cancer patients undergoing radical gastrectomy.
Ma X; Zhou X; Guo J; Feng X; Zhao M; Zhang P; Zhang C; Gong S; Wu N; Zhang Y; Zhang X; Ren Z; Zhang P
BMC Surg; 2024 Jan; 24(1):31. PubMed ID: 38263014
[TBL] [Abstract][Full Text] [Related]
43. TTI1 promotes non-small-cell lung cancer progression by regulating the mTOR signaling pathway.
Zhang LX; Yang X; Wu ZB; Liao ZM; Wang DG; Chen SW; Lu F; Wu YB; Zhu SQ
Cancer Sci; 2023 Mar; 114(3):855-869. PubMed ID: 36403197
[TBL] [Abstract][Full Text] [Related]
44. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
45. [The value of NLR, FIB, CEA and CA19-9 in colorectal cancer].
Qian X; Wang H; Ren Z; Jin F; Pan SY
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Apr; 55(4):499-505. PubMed ID: 33858062
[No Abstract] [Full Text] [Related]
46. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
[TBL] [Abstract][Full Text] [Related]
47. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
[TBL] [Abstract][Full Text] [Related]
48. Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.
He MM; Zhang DS; Wang F; Wang ZQ; Luo HY; Ren C; Jin Y; Chen DL; Xu RH
World J Gastroenterol; 2014 Jan; 20(1):264-73. PubMed ID: 24415881
[TBL] [Abstract][Full Text] [Related]
49. [Study of immunophenotypic characteristics, clinicopathological parameters and prognosis in gastric cancer microenvironment].
Wu Y; Chen YQ; Shi TG; Tan NJ; Chen WC
Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(35):2786-2794. PubMed ID: 37723053
[No Abstract] [Full Text] [Related]
50. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
[TBL] [Abstract][Full Text] [Related]
51. [The expression of neuraminidase-1 in Ewing sarcoma and its impact on sarcoma cell proliferation and migration].
Liu BF; Gao YZ
Zhonghua Yi Xue Za Zhi; 2023 Nov; 103(41):3287-3293. PubMed ID: 37926573
[No Abstract] [Full Text] [Related]
52. High expression of the circadian clock gene NPAS2 is associated with progression and poor prognosis of gastric cancer: A single-center study.
Cao XM; Kang WD; Xia TH; Yuan SB; Guo CA; Wang WJ; Liu HB
World J Gastroenterol; 2023 Jun; 29(23):3645-3657. PubMed ID: 37398880
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic and prognostic values of anti-helicobacter pylori antibody combined with serum CA724, CA19-9, and CEA for young patients with early gastric cancer.
Gong X; Zhang H
J Clin Lab Anal; 2020 Jul; 34(7):e23268. PubMed ID: 32118318
[TBL] [Abstract][Full Text] [Related]
54. Prognostic Significance of Carcinoembryonic Antigen Staining in Cancer Tissues of Gastric Cancer Patients.
Wang W; Seeruttun SR; Fang C; Chen J; Li Y; Liu Z; Zhan Y; Li W; Chen Y; Sun X; Li Y; Xu D; Guan Y; Zhou Z
Ann Surg Oncol; 2016 Apr; 23(4):1244-51. PubMed ID: 26620645
[TBL] [Abstract][Full Text] [Related]
55. [Analysis of risk factors and prognosis of No.8p lymph node metastasis in cases with advanced gastric cancer].
Chen L; Wei S; Ye Z; Zeng Y; Zheng Q; Xiao J; Wang Y; Zhuo C; Lin Z; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):218-223. PubMed ID: 28226359
[TBL] [Abstract][Full Text] [Related]
56. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
57. [Analysis of risk factor of perioperative complications in patients with radical gastrectomy for gastric cancer and its influence on prognosis].
Jin J; Deng J; Liang H; Sun C; Guo X; Guo J; Bai H; Liu H; Zhang N
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jan; 21(1):53-60. PubMed ID: 29354900
[TBL] [Abstract][Full Text] [Related]
58. The prognosis of gastric cancer patients with marginally elevated carcinoembryonic antigen (CEA) values after D2 radical gastrectomy.
Chen S; Feng XY; Li YF; Zhao BW; Zhou ZW; Chen YB
J Surg Oncol; 2013 May; 107(6):641-5. PubMed ID: 23297055
[TBL] [Abstract][Full Text] [Related]
59. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
Guo J; Dong B; Ji JF; Wu AW
World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
[TBL] [Abstract][Full Text] [Related]
60. CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
Hou W; Kong L; Hou Z; Ji H
BMC Med Genomics; 2022 Oct; 15(1):225. PubMed ID: 36316684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
